MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,960 Approvals
Showing 841 to 860 of 1,960 approvalsPage 43 of 98

Entecavir Accord

Authorisation: Sep 25, 2017

Symtuza

Authorisation: Sep 21, 2017

Tecentriq

Authorisation: Sep 20, 2017

Tecentriq

Authorisation: Sep 20, 2017

Tecentriq

Authorisation: Sep 20, 2017

Lacosamide Accord

Authorisation: Sep 18, 2017

Rydapt

Authorisation: Sep 18, 2017

Bavencio

Authorisation: Sep 18, 2017

Xermelo

Authorisation: Sep 17, 2017

Cuprior

Authorisation: Sep 5, 2017

Fotivda

Authorisation: Aug 24, 2017

Imraldi

Authorisation: Aug 24, 2017

Kisqali

Authorisation: Aug 22, 2017

Mavenclad

Authorisation: Aug 22, 2017

Vosevi

Authorisation: Jul 26, 2017

Maviret

Authorisation: Jul 26, 2017

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.